What is the appropriate digoxin maintenance dose after a standard intravenous loading dose in an adult with normal renal function, and how should the dose be adjusted for elderly patients or those with impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Digoxin Maintenance Dose After IV Load

For adults and pediatric patients over 10 years with normal renal function, start maintenance dosing at 2.4-3.6 mcg/kg/day (typically 0.125-0.25 mg daily), given once daily after completing the IV loading regimen. 1

Standard Maintenance Dosing for Adults

The FDA-approved maintenance dose for adults with normal renal function is:

  • 2.4-3.6 mcg/kg/day given once daily 1
  • This translates to 0.125-0.25 mg daily for most patients 2, 3

Use the lower end (0.125 mg daily or every other day) if the patient:

  • Is >70 years of age
  • Has impaired renal function
  • Has low lean body mass 2, 3

Higher doses (0.375-0.50 mg daily) are rarely needed and potentially harmful 2, 3.

Renal Function-Based Dosing

The maintenance dose must be adjusted based on creatinine clearance. For a 70 kg adult with varying renal function 1:

  • CrCl 100 mL/min: 238 mcg daily
  • CrCl 70 mL/min: 196 mcg daily
  • CrCl 50 mL/min: 168 mcg daily
  • CrCl 30 mL/min: 140 mcg daily
  • CrCl 10 mL/min: 112 mcg daily

Critical caveat: As renal function declines, the time to steady state increases dramatically—from 7 days at normal function to 19 days at CrCl 10 mL/min 1.

Alternative Dosing Formula

You can calculate maintenance dose using: 1

Total Maintenance Dose = Loading Dose × % Daily Loss/100

Where: % Daily Loss = 14 + (Creatinine clearance/5)

Target Serum Levels

Aim for serum digoxin concentrations <1.2 ng/mL to minimize mortality risk. Retrospective analyses demonstrate a linear relationship between mortality and digoxin levels, with significantly increased death risk at concentrations ≥1.2 ng/mL 2, 3.

Timing Considerations

  • Without loading dose: Steady state is reached in 7 days with normal renal function 1
  • With loading dose: Maintenance begins immediately after completing the loading regimen (typically after 12-24 hours) 1
  • Doses may be increased every 2 weeks based on clinical response, serum levels, and toxicity 1

Special Populations

Elderly patients (>70 years):

  • Start at 0.125 mg daily or every other day 2, 3
  • Lower lean body mass and reduced renal function increase toxicity risk

Obesity/edema:

  • Dose based on lean body weight, not total body weight 1
  • Abnormally high total body mass relative to lean mass requires dose reduction

Common Pitfalls

  1. Failing to adjust for renal function: This is the most common cause of toxicity—always calculate creatinine clearance before dosing 1
  2. Using therapeutic drug monitoring inappropriately: Serum levels correlate poorly with efficacy but strongly with toxicity; only check levels if toxicity is suspected 4
  3. Drug interactions: Amiodarone, verapamil, quinidine, and spironolactone increase digoxin levels—reduce maintenance dose by 50% when adding these agents 4
  4. Electrolyte abnormalities: Hypokalemia and hypomagnesemia dramatically increase toxicity risk even at therapeutic levels 4, 5

Contemporary Context

Recent guidelines downgrade digoxin to a Class 2b recommendation (may be considered) for symptomatic HFrEF despite GDMT, as it reduces hospitalizations but provides no mortality benefit 2, 3. The 2022 AHA/ACC/HFSA guidelines emphasize that digoxin should only be used after optimizing guideline-directed medical therapy with ACE inhibitors/ARNIs, beta-blockers, MRAs, and SGLT2 inhibitors.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.